STOCK TITAN

Hercules Capital Inc Stock Price, News & Analysis

HTGC NYSE

Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.

Hercules Capital Inc. (NYSE: HTGC) maintains this dedicated news hub for investors tracking its specialty financing activities in technology, life sciences, and renewable energy sectors. Access timely updates on the company’s venture debt solutions, including senior secured loans and strategic partnerships with venture-backed enterprises.

This resource consolidates all official press releases and market-relevant developments, from quarterly earnings to executive leadership updates. Users will find detailed information on financing agreements, portfolio company milestones, and regulatory filings – essential for understanding HTGC’s role in venture growth capital markets.

Key content includes updates on biotechnology sector lending, renewable energy project financing, and structured debt arrangements with emerging technology firms. The curated news flow helps stakeholders monitor how Hercules Capital supports high-growth companies through customized financing solutions.

Bookmark this page for direct access to primary source materials about HTGC’s market activities. Check regularly for insights into how the company navigates opportunities in venture debt financing while maintaining its position as a leading provider of non-dilutive growth capital.

Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has scheduled its fourth quarter and full-year 2021 financial results conference call for February 22, 2022, at 2:00 p.m. PT. Financial results will be released after market close on the same day. Investors can join the call by dialing (877) 304-8957, with access to a taped replay available for seven days. Hercules Capital, the largest specialty finance company providing venture growth loans, has committed over $13 billion to more than 540 companies since its inception in December 2003. The company also manages investments through Hercules Adviser LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has announced key internal promotions and a new addition to its executive management team. Christian Follmann has been promoted to Chief Operating Officer, Charlie Vandis to Chief Credit Officer, and Kiersten Zaza Botelho has joined as General Counsel and Chief Compliance Officer. The CEO, Scott Bluestein, emphasized the importance of these moves to enhance the company's capabilities and market position in venture and growth stage lending. Hercules has committed over $13 billion to more than 540 companies since its inception in 2003.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has successfully closed an underwritten public offering of $350 million in 3.375% notes due January 2027. Proceeds will be used to repay existing convertible notes, support investments, and for general corporate purposes. Moody’s assigned a Baa3 rating while Kroll rated it BBB+. The notes are unsecured, pay interest semiannually, and may be redeemed early at par plus a potential premium.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
Rhea-AI Summary

Hercules Capital has priced an underwritten public offering of $350 million in 3.375% notes maturing on January 20, 2027. The offering is subject to customary conditions and expected to close on January 20, 2022. Proceeds will be used to repay 4.375% convertible notes due 2022, fund investments, and for general corporate purposes. The company has committed over $13 billion since its inception in December 2003, focusing on growth loans for venture-backed companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
-
Rhea-AI Summary

NorthSea Therapeutics B.V. has successfully closed a USD 80 million Series C financing round, co-led by Ysios Capital and Forbion Growth. New investors include Hercules Capital. The funds will enhance the development of their pipeline focused on treating non-alcoholic steatohepatitis (NASH) and other metabolic diseases. The lead product, Icosabutate, has shown promising results in ongoing clinical trials, with plans to advance into phase 3 next year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has achieved a record $2.0 billion in gross debt and equity commitments year-to-date, surpassing its previous record of $1.47 billion. This milestone is attributed to the company's robust venture and growth stage lending platform and diverse strategies. CEO Scott Bluestein highlighted the importance of quality team dynamics and disciplined underwriting for long-term success. Hercules has committed over $13 billion since its inception in 2003 and continues to lead in providing growth loans to innovative companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has announced a new $100 million multi-currency credit facility with Sumitomo Mitsui Banking Corporation effective November 9, 2021. This facility features an accordion feature expandable to $150 million, with an interest rate of LIBOR plus 1.875% and a maximum advance rate of 75%. Additionally, Hercules recently completed a 5-year, $325 million investment-grade bond offering at 2.625%. These financial maneuvers aim to reduce capital costs and enhance operational flexibility for Hercules Capital.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) announced its participation in the Jefferies Sixth Annual Virtual BDC Summit on November 17, 2021, and the JMP Securities Financial Services and Real Estate Conference on November 18, 2021. The Company specializes in providing senior secured venture growth loans to high-growth companies in technology and life sciences. Since its inception in December 2003, Hercules has committed over $12.8 billion to more than 540 companies. Hercules also manages investments through its subsidiary, Hercules Adviser LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has announced a supplemental cash distribution of $0.07 per share, to be paid on November 17, 2021. This is in addition to the regular quarterly distribution of $0.33 per share for Q3 2021. The supplemental payment will come from undistributed taxable income as of September 30, 2021. The company maintains a distribution policy aiming to distribute approximately 90%-100% of its taxable income, with 88.6% of the current distributions categorized as Qualified Interest Income exempt from U.S. withholding tax for non-U.S. shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has declared a cash distribution of $0.33 per share for Q3 2021. The record date is set for November 10, 2021, with payment occurring on November 17, 2021. The company maintains a variable distribution policy to distribute approximately 90% to 100% of its taxable income. For Q3 2021, 88.6% of the declared distributions were classified as Qualified Interest Income (QII), which may be exempt from U.S. withholding tax for non-U.S. shareholders. Hercules has committed over $12.0 billion to more than 530 companies since its inception.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none

FAQ

What is the current stock price of Hercules Capital (HTGC)?

The current stock price of Hercules Capital (HTGC) is $18.95 as of July 14, 2025.

What is the market cap of Hercules Capital (HTGC)?

The market cap of Hercules Capital (HTGC) is approximately 3.2B.
Hercules Capital Inc

NYSE:HTGC

HTGC Rankings

HTGC Stock Data

3.23B
172.01M
1.71%
28.88%
2.65%
Asset Management
Financial Services
Link
United States
SAN MATEO